Transaction · 0000950170-25-036694

Rodino-Klapac Louise

Rodino-Klapac Louise, HR, D, CSO, reported a transaction classified as withholding at Sarepta Therapeutics, Inc. involving 7990.000000 shares for an estimated $828563.00. Reported holdings after the transaction were 74318.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FHR, D, CSO
SRPTSarepta Therapeutics, Inc.
Filing timeMar 11
Trade dateMar 07, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

SRPT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
SRPT since 2025-03-11Filed 547 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0000950170-25-036694
Common Stock
Transaction date
Mar 07, 2025
Filed Mar 11, 2025, 12:00 AM · 4d delay
Shares
7.99k sh
$10.3k per share
Estimated value
-$82.8M
Computed from shares × price
Holdings after
74.3k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Head of R&D, CSO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents the number of shares vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committe…

  2. F2

    Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.

  3. F3

    Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023.

Original filing · 0000950170-25-036694
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

SRPT